Zhang K - Search Results

1

Erratum: Recombinant Mutated Human TNF in Combination with Chemotherapy for Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Phase III Study.

Ma X, Song Y, Zhang K, Shang L, Gao Y, Zhang W, Xue X, Jia H, Geng J, Zhou W, Dang Y, Li E, Ti X, Fan F, Zhang Y, Li M. Ma X, et al. Among authors: zhang w, zhang k, zhang y. Sci Rep. 2018 Mar 19;8:46953. doi: 10.1038/srep46953. Sci Rep. 2018. PMID: 29553131 Free PMC article.

2

Mimotope vaccination for epitope-specific induction of anti-VEGF antibodies.

Li W, Ran Y, Li M, Zhang K, Qin X, Xue X, Zhang C, Hao Q, Zhang W, Zhang Y. Li W, et al. Among authors: zhang c, zhang w, zhang k, zhang y. BMC Biotechnol. 2013 Sep 27;13:77. doi: 10.1186/1472-6750-13-77. BMC Biotechnol. 2013. PMID: 24073737 Free PMC article.

3

UXT is a novel regulatory factor of regulatory T cells associated with Foxp3.

Li W, Wang L, Jiang C, Li H, Zhang K, Xu Y, Hao Q, Li M, Xue X, Qin X, Zhang C, Wang H, Zhang W, Zhang Y. Li W, et al. Among authors: zhang c, zhang w, zhang k, zhang y. Eur J Immunol. 2014 Feb;44(2):533-44. doi: 10.1002/eji.201343394. Epub 2013 Nov 29. Eur J Immunol. 2014. PMID: 24136450 Free PMC article.

4

Growth differentiation factor-15 suppresses maturation and function of dendritic cells and inhibits tumor-specific immune response.

Zhou Z, Li W, Song Y, Wang L, Zhang K, Yang J, Zhang W, Su H, Zhang Y. Zhou Z, et al. Among authors: zhang w, zhang k, zhang y. PLoS One. 2013 Nov 13;8(11):e78618. doi: 10.1371/journal.pone.0078618. eCollection 2013. PLoS One. 2013. PMID: 24236027 Free PMC article.

5

Recombinant mutated human TNF in combination with chemotherapy for stage IIIB/IV non-small cell lung cancer: a randomized, phase III study.

Ma X, Song Y, Zhang K, Shang L, Gao Y, Zhang W, Xue X, Jia H, Geng J, Zhou W, Dang Y, Li E, Ti X, Fan F, Zhang Y, Li M. Ma X, et al. Among authors: zhang w, zhang k, zhang y. Sci Rep. 2015 Apr 21;4:9918. doi: 10.1038/srep09918. Sci Rep. 2015. PMID: 25897826 Free PMC article. Clinical Trial.

6

FOXP3 inhibits cancer stem cell self-renewal via transcriptional repression of COX2 in colorectal cancer cells.

Liu S, Zhang C, Zhang K, Gao Y, Wang Z, Li X, Cheng G, Wang S, Xue X, Li W, Zhang W, Zhang Y, Xing X, Li M, Hao Q. Liu S, et al. Among authors: zhang c, zhang w, zhang k, zhang y. Oncotarget. 2017 Jul 4;8(27):44694-44704. doi: 10.18632/oncotarget.17974. Oncotarget. 2017. PMID: 28591725 Free PMC article.

7

Local blockage of self-sustainable erythropoietin signaling suppresses tumor progression in non-small cell lung cancer.

He L, Wu S, Hao Q, Dioum EM, Zhang K, Zhang C, Li W, Zhang W, Zhang Y, Zhou J, Pang Z, Zhao L, Ma X, Li M, Zhang Q. He L, et al. Among authors: zhang c, zhang q, zhang w, zhang k, zhang y. Oncotarget. 2017 Jul 18;8(47):82352-82365. doi: 10.18632/oncotarget.19354. eCollection 2017 Oct 10. Oncotarget. 2017. PMID: 29137269 Free PMC article.

8

Synergistic tumoricidal effect of combined hPD-L1 vaccine and HER2 gene vaccine.

Zhang W, Wang S, Gu J, Gao Y, Wang Z, Zhang K, Mu N, Huang T, Li W, Hao Q, Xue X, Zhang W, Zhang Y, Zhang C. Zhang W, et al. Among authors: zhang c, zhang k, zhang y. Biochem Biophys Res Commun. 2018 Feb 26;497(1):394-400. doi: 10.1016/j.bbrc.2018.02.092. Epub 2018 Feb 10. Biochem Biophys Res Commun. 2018. PMID: 29438713

9

Nuclear galectin-1-FOXP3 interaction dampens the tumor-suppressive properties of FOXP3 in breast cancer.

Gao Y, Li X, Shu Z, Zhang K, Xue X, Li W, Hao Q, Wang Z, Zhang W, Wang S, Zeng C, Fan D, Zhang W, Zhang Y, Zhao H, Li M, Zhang C. Gao Y, et al. Among authors: zhang c, zhang w, zhang k, zhang y. Cell Death Dis. 2018 Apr 1;9(4):416. doi: 10.1038/s41419-018-0448-6. Cell Death Dis. 2018. PMID: 29549328 Free PMC article.

10

Acetylation and Amination Protect Angiotensin 1-7 from Physiological Hydrolyzation and Therefore Increases Its Antitumor Effects on Lung Cancer.

Ma X, Pang Z, Zhou J, He L, Hao Q, Li W, Zhang K, Wang S, Zhang W, Xue X, Zhang W, Zhang Y, Zhang C, Li M. Ma X, et al. Among authors: zhang c, zhang w, zhang k, zhang y. Mol Pharm. 2018 Jun 4;15(6):2338-2347. doi: 10.1021/acs.molpharmaceut.8b00181. Epub 2018 Apr 27. Mol Pharm. 2018. PMID: 29685037

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26,071 results

Search Page